{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:35Z","timestamp":1791201935469,"version":"4.2.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10549-014-3030-7","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T05:09:18Z","timestamp":1404277758000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women"],"prefix":"10.1007","volume":"146","author":[{"given":"Yong","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Deming-Halverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha J.","family":"Shrubsole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Beeghly-Fadiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alecia M.","family":"Fair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,2]]},"reference":[{"issue":"6917","key":"3030_CR1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867","journal-title":"Nature"},{"issue":"7203","key":"3030_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436\u2013444. doi: 10.1038\/nature07205","journal-title":"Nature"},{"issue":"5","key":"3030_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg PA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. doi: 10.1016\/j\/cell.2011.02.013","journal-title":"Cell"},{"key":"3030_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-540-69297-3_20","volume":"181","author":"MJ Thun","year":"2009","unstructured":"Thun MJ, Blackard B (2009) Pharmacologic effects of NSAIDs and implications for the risks and benefits of long-term prophylactic use of aspirin to prevent cancer. Recent Results Cancer Res 181:215\u2013221","journal-title":"Recent Results Cancer Res"},{"issue":"9671","key":"3030_CR5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","volume":"373","author":"PC Elwood","year":"2009","unstructured":"Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G (2009) Aspirin, salicylates, and cancer. Lancet 373(9671):1301\u20131309. doi: 10.1016\/S0140-6736(09)60243-9","journal-title":"Lancet"},{"issue":"20","key":"3030_CR6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998) Cyclooxygenase-2 inhibit tumorigenesis (part I). J Natl Cancer Inst 90(20):1529\u20131536","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3030_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","volume":"119","author":"JY Park","year":"2006","unstructured":"Park JY, Pillinger MH, Abramson SB (2006) Prostagladin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 119(3):229\u2013240","journal-title":"Clin Immunol"},{"issue":"4","key":"3030_CR8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr1678","volume":"9","author":"LR Howe","year":"2007","unstructured":"Howe LR (2007) Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer. Breast Cancer Res 9(4):210","journal-title":"Breast Cancer Res"},{"issue":"3","key":"3030_CR9","first-page":"632","volume":"62","author":"A Ristimaki","year":"2002","unstructured":"Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62(3):632\u2013635","journal-title":"Cancer Res"},{"issue":"3","key":"3030_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10(3):181\u2013193. doi: 10.1038\/nrc2809","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"3030_CR11","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291(20):2433\u20132440","journal-title":"JAMA"},{"issue":"20","key":"3030_CR12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jnci\/djn324","volume":"100","author":"B Takkouche","year":"2008","unstructured":"Takkouche B, Regueira-M\u00e9ndez C, Etminan M (2008) Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 100(20):1439\u20131447. doi: 10.1093\/jnci\/djn324","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3030_CR13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-011-1747-0","volume":"131","author":"T Luo","year":"2012","unstructured":"Luo T, Yan HM, He P, Lou Y, Yang YF, Zheng H (2012) Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 131(2):581\u2013587. doi: 10.1007\/s10549-011-1747-0","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3030_CR14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","volume":"112","author":"KE Wellen","year":"2003","unstructured":"Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112(12):1785\u20131788","journal-title":"J Clin Invest"},{"issue":"9","key":"3030_CR15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(9):911\u2013919","journal-title":"J Allergy Clin Immunol"},{"key":"3030_CR16","first-page":"697521","volume":"2013","author":"ME Ramos-Nino","year":"2013","unstructured":"Ramos-Nino ME (2013) The role of chronic inflammation in obesity-associated cancers. ISRN Oncol 2013:697521. doi: 10.1155\/2013\/697521","journal-title":"ISRN Oncol"},{"issue":"5","key":"3030_CR17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/1940-6207.CAPR-12-0431","volume":"6","author":"PG Morris","year":"2013","unstructured":"Morris PG, Zhou XK, Milne GL, Goldstein D, Hawks LC, Dang CT, Modi S, Fornier MN, Hudis CA, Dannenberg AJ (2013) Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prev Res (Phila) 6(5):428\u2013436. doi: 10.1158\/1940-6207.CAPR-12-0431","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"3030_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2159-8290.CD-11-0241","volume":"2","author":"K Subbaramaiah","year":"2012","unstructured":"Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, Kopelovich L, Hudis CA, Dannenberg AJ (2012) (2012) Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2(4):356\u2013365. doi: 10.1158\/2159-8290.CD-11-0241","journal-title":"Cancer Discov"},{"issue":"10","key":"3030_CR19","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/aje\/kwm195","volume":"166","author":"JK Gill","year":"2007","unstructured":"Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN (2007) Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol 166(10):1150\u20131158","journal-title":"Am J Epidemiol"},{"issue":"2","key":"3030_CR20","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2089","volume":"10","author":"GL Gierach","year":"2008","unstructured":"Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA (2008) Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res 10(2):R38. doi: 10.1186\/bcr2089","journal-title":"Breast Cancer Res"},{"issue":"1","key":"3030_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.22656","volume":"121","author":"L Gallicchio","year":"2007","unstructured":"Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ (2007) Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington county. MD Int J Cancer 121(1):211\u2013215","journal-title":"MD Int J Cancer"},{"issue":"1","key":"3030_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-010-1074-x","volume":"126","author":"A Bardia","year":"2011","unstructured":"Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR (2011) Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 126(1):149\u2013155. doi: 10.1007\/s10549-010-1074-x","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3030_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/aje\/kwi182","volume":"162","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 162(2):165\u2013170","journal-title":"Am J Epidemiol"},{"issue":"6","key":"3030_CR24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/aje\/kwm216","volume":"166","author":"VA Kirsh","year":"2007","unstructured":"Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B (2007) Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol 166(6):709\u2013716","journal-title":"Am J Epidemiol"},{"issue":"11","key":"3030_CR25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97(11):805\u2013812","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"3030_CR26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604240","volume":"98","author":"SM Zhang","year":"2008","unstructured":"Zhang SM, Cook NR, Manson JE, Lee IM, Buring JE (2008) Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial. Br J Cancer 98(5):989\u2013991. doi: 10.1038\/sj.bjc.6604240","journal-title":"Br J Cancer"},{"issue":"7","key":"3030_CR27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10552-011-9769-9","volume":"22","author":"TM Brasky","year":"2011","unstructured":"Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22(7):965\u2013975. doi: 10.1007\/s10552-011-9769-9","journal-title":"Cancer Causes Control"},{"issue":"28","key":"3030_CR28","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1200\/JCO.2012.42.2006","volume":"30","author":"X Zhang","year":"2012","unstructured":"Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE (2012) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol 30(28):3468\u20133477","journal-title":"J Clin Oncol"},{"issue":"10","key":"3030_CR29","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","volume":"18","author":"RCM Kruijsdijk van","year":"2009","unstructured":"van Kruijsdijk RCM, van der Wall E, Visseren FL (2009) Obesity and Cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev 18(10):2569\u20132578. doi: 10.1158\/1055-9965.EPI-09-0372","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"18","key":"3030_CR30","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A, Initiative Women\u2019s Health (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women\u2019s Health Initiative. Cancer Res 63(18):6096\u20136101","journal-title":"Cancer Res"},{"issue":"6","key":"3030_CR31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1524-4741.2009.00822.x","volume":"15","author":"CA Parise","year":"2009","unstructured":"Parise CA, Bauer KR, Brown MM, Caggiano V (2009) Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J 15(6):593\u2013602. doi: 10.1111\/j.1524-4741.2009.00822.x","journal-title":"Breast J"},{"issue":"6","key":"3030_CR32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jnci\/dji064","volume":"97","author":"RT Chlebowski","year":"2005","unstructured":"Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439\u2013448","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3030_CR33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10549-009-0447-5","volume":"119","author":"Y Liu","year":"2010","unstructured":"Liu Y, Diamant AL, Thind A, Maly RC (2010) Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer. Breast Cancer Res Treat 119(3):745\u2013751. doi: 10.1007\/s10549-009-0447-5","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3030_CR34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jclinepi.2004.09.005","volume":"58","author":"E Maunsell","year":"2005","unstructured":"Maunsell E, Drolet M, Ouhoummane N, Robert J (2005) Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol 58(4):364\u2013369","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"3030_CR35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jclinepi.2005.04.002","volume":"58","author":"M Schootman","year":"2005","unstructured":"Schootman M, Jeffe DB, West MM, Aft R (2005) Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data. J Clin Epidemiol 58(12):1316\u20131319","journal-title":"J Clin Epidemiol"},{"issue":"21","key":"3030_CR36","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2005.03.002","volume":"23","author":"KA Phillips","year":"2005","unstructured":"Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL (2005) Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol 23(21):4679\u20134686","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-3030-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-3030-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:47:33Z","timestamp":1559234853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-3030-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["3030"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-3030-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}